Filters

See more specimen types...

Other countries

Results: 1 to 20 of 64 (representing 23 labs)

Tests names and labsConditionsGenes and analytesMethods

Limb-Girdle Muscular Dystrophy Sequencing Panel

Genetic Services Laboratory University of Chicago
United States
4630
  • C Sequence analysis of the entire coding region

Limb-Girdle Muscular Dystrophy Deletion/Duplication Panel

Genetic Services Laboratory University of Chicago
United States
3925
  • D Deletion/duplication analysis

Congenital Myopathy Sequencing Panel

Genetic Services Laboratory University of Chicago
United States
3026
  • C Sequence analysis of the entire coding region

Congenital Myopathy Deletion/Duplication Analysis

Genetic Services Laboratory University of Chicago
United States
3224
  • D Deletion/duplication analysis

Neuromuscular Disorders Sequencing Panel

Genetic Services Laboratory University of Chicago
United States
119111
  • C Sequence analysis of the entire coding region

AllNeuro panel

Centogene AG - the Rare Disease Company
Germany
7861205
  • C Sequence analysis of the entire coding region

Limb-Girdle Muscular Dystrophy, autosomal recessive type 2J

Centogene AG - the Rare Disease Company
Germany
11
  • D Deletion/duplication analysis
  • E Sequence analysis of select exons
  • T Targeted variant analysis

Pan Cardiomyopathy Panel (62 Genes)

Laboratory for Molecular Medicine Partners HealthCare Personalized Medicine
United States
10361
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

DCM/Arrhythmogenic Cardiomyopathy Panel (53 Genes)

Laboratory for Molecular Medicine Partners HealthCare Personalized Medicine
United States
9853
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Comprehensive Neuromuscular Sequencing Panel

PreventionGenetics
United States
148124
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Arrythmogenic Cardiomyopathy Panel

Health in Code S.L.
Spain
5517
  • C Sequence analysis of the entire coding region

TTN. Sequencing of the exons: 18, 186, 308, 342, 356 and 363

Instituto de Medicina Genomica
Spain
11
  • E Sequence analysis of select exons

Centronuclear Myopathy Sequencing Panel

PreventionGenetics
United States
66
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Limb-Girdle Muscular Dystrophy (LGMD) Sequencing Panel

PreventionGenetics
United States
3233
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Distal Hereditary Myopathy Sequencing Panel

PreventionGenetics
United States
2220
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Autosomal Recessive Limb-Girdle Muscular Dystrophy (LGMD) Sequencing Panel

PreventionGenetics
United States
2324
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Autosomal Dominant Limb-Girdle Muscular Dystrophy (LGMD) Sequencing Panel

PreventionGenetics
United States
1010
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Limb Girdle Muscular Dystrophy, Type 2J and Tibial Muscular Dystrophy via the TTN Gene (exons 307 - 312)

PreventionGenetics
United States
21
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Neuromuscular Disorders Panel

Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center
United States
244144
  • C Sequence analysis of the entire coding region

Limb-Girdle Muscular Dystrophy Type 2J, Sequencing Selected Exons TTN Gene

Reference Laboratory Genetics
Spain
11
  • E Sequence analysis of select exons

Results: 1 to 20 of 64

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.

Support Center